ArticleClinical epigenetics2026
A maternal exon H splice-site variant leading to pseudohypoparathyroidism type 1B with broad methylation defects in GNAS-differentially methylated regions.
Article in Clinical epigenetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe GNAS locus produces multiple transcripts, including the maternally derived, GNAS-H, and GNAS-NESP55 and the paternally derived GNAS-XL, GNAS-A/B, and GNAS-AS, all of which are expressed in specific tissues. GNAS-Gsα is biparentally expressed in most tissues and imprinted in several tissues, specifically, the proximal tubules, thyroid, gonads, and pituitary. These imprinted transcripts are regulated by five differentially methylated regions (GNAS-DMRs), and hypomethylation in the GNAS-A/B:TSS-DMR causes resistance to hormones, including parathyroid hormone, leading to pseudohypoparathyroidism type 1B (PHP1B). Sporadic PHP1B shows broad methylation defects in the GNAS-DMRs, whereas most familial PHP1B cases show localized methylation defects at the GNAS-A/B:TSS-DMR and GNAS-AS2:TSS-DMR. We identified an inherited maternal exon H variant that causes a GNAS methylation pattern typically observed in sporadic PHP1B.
resultsTo determine the underlying genetic cause in this family, we conducted long-read sequencing (LRS). LRS revealed a maternal exon H variant together with methylation defects of CpGs in the GNAS-DMRs. To evaluate the association of the variant with this familial PHP1B, we established patient-derived induced pluripotent stem cells (iPSCs). Reverse-transcription PCR (RT-PCR) and quantitative RT-PCR in patient-derived iPSCs showed no expression of GNAS-NESP55 or GNAS-H and increased expression of GNAS-AS, together with hypermethylation of the GNAS-NESP:TSS-DMR and hypomethylation of the GNAS-AS1:TSS-DMR and GNAS-XL:Ex1-DMR. RNA sequencing revealed no abnormal GNAS transcripts in iPSCs established from patients. To determine whether loss of GNAS-H expression itself causes PHP1B, or whether methylation defects of the GNAS-DMRs, followed by loss of GNAS-H expression, result in PHP1B in this family, we conducted RT-PCR after demethylation treatment in patient-derived iPSCs. We detected biallelic expressed GNAS-NESP55 transcript and only paternally expressed GNAS-H transcript. These findings indicated impaired maternal GNAS-H transcription in the patients, regardless of the methylation levels in the GNAS-DMRs. Furthermore, amplicon LRS spanning the region from exon H to GNAS-AS exon 1 in 40 sporadic PHP1B patients showed that genomic variants in this region are infrequent.
conclusionLoss of maternal GNAS-H transcript precedes the onset of abnormal methylation imprinting at the GNAS-DMRs and contributes to its establishment. We also revealed that LRS is useful for diagnosing and researching imprinting disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.